Cover Image
市場調查報告書

合成生物學市場預測:XNAS·底盤有機體·寡核甘酸等

Synthetic Biology Market: By Tool (XNAS, Chassis Organisms, Oligonucleotides, etc); By Technology (DNA Synthesis & Sequencing, Computational Modelling, Bioinformatics, Microfluidics, etc); By Application; By Geography - (2015-2023)

出版商 IndustryARC 商品編碼 622687
出版日期 內容資訊 英文 153 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
合成生物學市場預測:XNAS·底盤有機體·寡核甘酸等 Synthetic Biology Market: By Tool (XNAS, Chassis Organisms, Oligonucleotides, etc); By Technology (DNA Synthesis & Sequencing, Computational Modelling, Bioinformatics, Microfluidics, etc); By Application; By Geography - (2015-2023)
出版日期: 2017年08月30日 內容資訊: 英文 153 Pages
簡介

本報告提供全球合成生物學性市場調查,彙整市場定義和概要,競爭環境與市場佔有率,市場的各種影響因素及市場機會分析,價值鏈,市場生命週期,各工具·技術·用途·地區/主要國家趨勢與市場規模的變化與預測,主要企業簡介等資訊。

第1章 市場概要

第2章 摘要整理

第3章 市場環境

  • 市場佔有率分析
  • 終端用戶的分析
  • 競爭經營者的基準
  • 財務分析

第4章 市場影響因素

  • 成長推進因素
  • 阻礙成長要素·課題
  • 市場魅力

第5章 策略性市場分析

  • 價值鏈分析
  • 價格分析
  • 市場機會分析
  • 市場生命週期

第6章 合成生物學市場分析·預測:各工具

  • 簡介
  • XNAS
  • 底盤有機體
  • 寡核甘酸
  • 基因複製技術套組
  • 酵素

第7章 合成生物學市場分析·預測:各技術

  • 簡介
  • DNA合成
  • DNA定序
  • computer model
  • 生物資訊學技術
  • 微流體技術
  • 奈米技術
  • 通路技術
  • 其他

第8章 合成生物學市場分析·預測:各用途

  • 簡介
  • 環境
    • 生物修復
    • 全細胞生物傳感器
  • 醫療
    • 藥物研發·治療
    • 醫藥品
    • 人工組織·組織再生
  • 工業用途
    • 生質燃料·再生能源
    • 產業用酵素
    • 生物材料·綠色化學

第9章 合成生物學市場分析·預測:各地區

  • 簡介
  • 南北美洲
    • 美國
    • 加拿大
    • 墨西哥
    • 巴西
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 韓國
    • 日本
    • 印度
    • 其他
  • 其他
    • 中東
    • 非洲

第10章 市場熵

第11章 企業簡介

  • Ingenza Ltd
  • Intrexon Corporation
  • Ziopharm Oncology Inc
  • Cargill Incorporated
  • Novozymes
  • OriGene Technologies, Inc
  • Green Biologics Limited
  • Evolva
  • Codexis, Inc.
  • Halozyme Inc.
  • Integrated DNA Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Algenol Biotech
  • Amyris Inc
  • BioAmber Inc
目錄

Synthetic Biology industry refers to the application of engineering principles to the fundamental components of Biology. It involves the concepts of various subjects like genetic engineering, biotechnology, biophysics, computer engineering, molecular biology, and evolutionary biology. Synthetic biology exactly deals with the design and fabrication of biological components that does not exist and also the redesign of the existing biological components. It creates an artificial life using unnatural components. It also uses natural components and assembles them into a system that acts unnaturally. Synthetic biology majorly involves the activities such as DNA coding, synthetic genes, bioinformatics, processing of various biological components, genome engineering and so on.

Synthetic Biology market is segmented based on tools, technology, applications and geography. Tools considered in the report are Xeno-Nucleic Acids (Xnas), Chassis Organisms, Oligonucleotides, Cloning Technology Kits and Enzymes. Researchers and companies involved in synthetic biology are synthesizing enzymes with high activity to produce products with optimal yields and effectiveness. Various technologies in biotechnology includes DNA Synthesis, DNA sequencing, Computational Modelling, Bioinformatics Technologies, Microfluidics Technologies, Nanotechnology, Pathway Engineering and others. The market report also provides analysis of synthetic biology applications in environmental, medical and industrial sectors. Rising demand for improved drugs and vaccines has been attracting investments globally into the healthcare sector. The synthetic biology market is thus set to witness significant growth in coming years owing to the strong investments from both public and private sector.

Sample Companies Profiled in this Report are:

Intrexon Corporation (U.S)

Thermo Fisher Scientific, Inc. (U.S.)

Amyris Inc (U.S.)

GenScript Biotech Corporation (China)

Synthetic Genomics Inc (U.S.).

10+

The other companies in the market held low share owing to the high entry barrier in the market and capital intensiveness for research and development.

1.Synthetic Biology Market Overview

2.Synthetic Biology Market Executive Summary

3.Synthetic Biology Market Landscape

  • 3.1.Market share Analysis
  • 3.2.End User Profiling
  • 3.3.Competitor Benchmarking
  • 3.4.Financial Analysis

4.Synthetic Biology Market Forces

  • 4.1.Market Drivers
    • 4.1.1.Strong Investments in Synthetic Biology
    • 4.1.2.Developments in Production of Bio-Based Chemicals and Fuels
    • 4.1.3.Rising Demand for Improved Drugs and Vaccines
    • 4.1.4.Advancement in Molecular Biology
    • 4.1.5.Wide Spread Application of Synthetic Biology
  • 4.2.Market Challenges/Constraints
    • 4.2.1.Rising Biosecurity Issues
    • 4.2.2.Ethical Concerns and Stringent Regulations
  • 4.3.Attractiveness of the Synthetic Biology Market
    • 4.3.1.Power of Suppliers
    • 4.3.2.Power of Customers
    • 4.3.3.Threat of New entrants
    • 4.3.4.Threat of Substitution
    • 4.3.5.Degree of Competition

5.Synthetic Biology Market - Strategic Analysis

  • 5.1.Value Chain Analysis
  • 5.2.Pricing Analysis
  • 5.3.Opportunity Analysis
    • 5.3.1.Rising Concerns on Fuel Consumption
    • 5.3.2.Growing Demand for Therapeutics
  • 5.4.Market Lifecycle Analysis

6.Synthetic Biology Market - By Tool

  • 6.1.Introduction
  • 6.2.Xeno-Nucleic Acids (Xnas)
  • 6.3.Chassis Organisms
  • 6.4.Oligonucleotides
  • 6.5.Cloning Technology Kits
  • 6.6.Enzymes

7.Synthetic Biology Market - By Technology

  • 7.1.Introduction
  • 7.2.DNA Synthesis
  • 7.3.DNA sequencing
  • 7.4.Computational Modelling
  • 7.5.Bioinformatics Technologies
  • 7.6.Microfluidics Technologies
  • 7.7.Nanotechnology
  • 7.8.Pathway Engineering
  • 7.9.Other

8.Synthetic Biology Market - By Application

  • 8.1.Introduction
  • 8.2.Environmental Application
    • 8.2.1.Bioremediation
    • 8.2.2.Whole-Cell Biosensors
  • 8.3.Medical Applications
    • 8.3.1.Drug Discovery and Therapeutics
    • 8.3.2.Pharmaceuticals
    • 8.3.3.Artificial Tissue and Tissue Regeneration
  • 8.4.Industrial Applications
    • 8.4.1.Biofuel and Renewable Energy
    • 8.4.2.Industrial Enzyme
    • 8.4.3.Biomaterials & Green Chemicals

9.Synthetic Biology Market - By Geography

  • 9.1.Introduction
  • 9.2.Americas
    • 9.2.1.U.S.
    • 9.2.2.Canada
    • 9.2.3.Mexico
    • 9.2.4.Brazil
    • 9.2.5.Rest of Americas
  • 9.3.Europe
    • 9.3.1.U.K.
    • 9.3.2.Germany
    • 9.3.3.Italy
    • 9.3.4.Russia
    • 9.3.5.Rest of Europe
  • 9.4.APAC
    • 9.4.1.China
    • 9.4.2.South Korea
    • 9.4.3.Japan
    • 9.4.4.India
    • 9.4.5.Rest of APAC
  • 9.5.RoW
    • 9.5.1.Middle East
    • 9.5.2.Africa

10.Synthetic Biology Market Entropy

11.Synthetic Biology Market - Company Profiles

  • 11.1.Ingenza Ltd (U.K.)
  • 11.2.Intrexon Corporation (U.S)
  • 11.3.Ziopharm Oncology Inc (U.S)
  • 11.4.Cargill Incorporated (U.S.)
  • 11.5.Novozymes (Denmark)
  • 11.6.OriGene Technologies, Inc (U.S.)
  • 11.7.Green Biologics Limited (U.K.)
  • 11.8.Evolva (Switzerland)
  • 11.9.Codexis, Inc. (U.S.)
  • 11.10.Halozyme Inc. (U.S.)
  • 11.11.Integrated DNA Technologies, Inc. (U.S.)
  • 11.12.Thermo Fisher Scientific, Inc. (U.S.)
  • 11.13.Algenol Biotech (U.S.)
  • 11.14.Amyris Inc (U.S.)
  • 11.15.BioAmber Inc (Canada)

More than 10 Companies are profiled in this Research Report*

"*Financials would be provided on a best efforts basis for private companies"

Back to Top